Safety and management of new primary melanomas during receipt of BRAF inhibitors

J Clin Oncol. 2014 Oct 1;32(28):3202. doi: 10.1200/JCO.2014.55.0590. Epub 2014 Sep 2.

Authors

Marie Perier-Muzet¹, Luc Thomas², Stéphane Dalle³

Affiliations

¹ Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon; and University Claude Bernard Lyon 1, Lyon, France.
² Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon; University Claude Bernard Lyon 1; and Cancer Research Center of Lyon, Lyon, France.
³ Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon; and University Claude Bernard Lyon 1, Lyon, France stephane.dalle@chu-lyon.fr.

PMID: 25185098
DOI: 10.1200/JCO.2014.55.0590

No abstract available

Publication types

Letter
Comment

MeSH terms

Female
Humans
Male
Melanoma / epidemiology*
Neoplasms, Second Primary / epidemiology*
Skin Neoplasms / epidemiology*